Jazz Pharmaceuticals Ownership | Who Owns Jazz Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Jazz Pharmaceuticals Ownership Summary


Jazz Pharmaceuticals is owned by 93.58% institutional investors, 2.94% insiders, and 3.48% retail investors. Vanguard group is the largest institutional shareholder, holding 10.11% of JAZZ shares. Pacer US Cash Cows 100 ETF is the top mutual fund, with 3.49% of its assets in Jazz Pharmaceuticals shares.

JAZZ Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockJazz Pharmaceuticals93.58%2.94%3.48%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%
IdeaCannabis Stocks List15.77%7.93%76.29%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group6.32M10.11%$674.82M
Blackrock6.15M9.83%$655.94M
Lsv asset management2.48M3.97%$264.75M
Capital world investors2.02M3.23%$215.55M
State street2.02M3.23%$215.31M
Pacer advisors1.82M2.91%$194.35M
Jpmorgan chase1.54M2.46%$164.19M
Vestal point capital, lp1.50M2.40%$160.09M
Ameriprise financial1.46M2.34%$155.97M
Polaris capital management1.38M2.20%$146.80M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Vestal point capital, lp1.50M11.94%$160.09M
Estuary capital management lp267.44K9.20%$28.54M
Polaris capital management1.38M7.87%$146.80M
Krensavage asset management109.08K5.35%$11.64M
Camber capital management lp1.15M3.40%$122.74M
Ecor1 capital1.01M3.31%$108.22M
Avidity partners management lp544.50K2.47%$58.11M
Graphene investments sas31.40K2.11%$3.35M
Fairbanks capital management27.11K1.90%$2.89M
Tang capital management140.00K1.52%$14.94M

Top Buyers

HolderShares% AssetsChange
Swedbank ab1.00M0.14%1.00M
Capital world investors2.02M0.04%591.71K
Pacer advisors1.82M0.44%527.19K
Vestal point capital, lp1.50M11.94%400.00K
Dimensional fund advisors lp1.22M0.03%398.55K

Top Sellers

HolderShares% AssetsChange
Baupost group llc/ma---1.27M
Blackrock6.15M0.01%-924.16K
Rubric capital management lp---616.62K
Fuller & thaler asset management469.67K0.21%-615.47K
State street2.02M0.01%-444.83K

New Positions

HolderShares% AssetsChangeValue
Swedbank ab1.00M0.14%1.00M$106.94M
Tang capital management140.00K1.52%140.00K$14.94M
Distillate capital partners131.42K0.74%131.42K$14.03M
Susquehanna fundamental investments106.75K0.26%106.75K$11.39M
Corebridge financial79.72K0.05%79.72K$8.51M

Sold Out

HolderChange
Harbor investment advisory-1.00
Center for financial planning-1.00
Financial gravity asset management-2.00
Rfp financial group-2.00
Advisornet financial-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20244732.83%57,472,0080.00%931.12%2357.31%155-6.06%
Jun 30, 2024456-6.37%57,467,965-0.65%911.10%218-6.84%1620.62%
Mar 31, 2024487-4.32%57,846,6723.04%911.16%234-0.85%161-10.56%
Dec 31, 20235093.25%56,141,8891.42%881.19%2367.76%1800.56%
Sep 30, 20234933.14%55,355,905-0.53%861.13%2197.88%1797.83%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Pacer US Cash Cows 100 ETF2.11M3.49%2.62K
iShares Core S&P Mid-Cap ETF1.98M3.28%3.89K
Vanguard Total Stock Mkt Idx Inv1.83M3.03%-7.63K
American Funds Fundamental Invs A1.80M2.91%-199.74K
Capital Group Fundamental Invtrs Comp1.80M2.91%-199.74K
Vanguard Small Cap Index1.47M2.43%2.90K
Vanguard Small Cap Value Index Inv994.03K1.64%-344.00
Vanguard Institutional Extnd Mkt Idx Tr918.72K1.52%-6.03K
JPM US Mid Cap Value-MA855.85K1.39%-
JPM US Mid Cap Value-Composite855.85K1.39%-9.39K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 02, 2024COZADD BRUCE C Chairman & CEOSell$242.34K
Dec 02, 2024Carr Patricia SVP, Chief Accounting OfficerSell$6.49K
Nov 08, 2024Patil Neena M EVP & Chief Legal OfficerSell$456.62K
Nov 01, 2024COZADD BRUCE C Chairman & CEOSell$110.84K
Sep 06, 2024Henderson Mary Elizabeth SVP, Technical OperationsSell$152.70K

Insider Transactions Trends


DateBuySell
2024 Q4-4
2024 Q3-1
2024 Q2-2
2024 Q113
2023 Q4-2

JAZZ Ownership FAQ


Who Owns Jazz Pharmaceuticals?

Jazz Pharmaceuticals shareholders are primarily institutional investors at 93.58%, followed by 2.94% insiders and 3.48% retail investors. The average institutional ownership in Jazz Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Jazz Pharmaceuticals exceeds.

Who owns the most shares of Jazz Pharmaceuticals?

Jazz Pharmaceuticals’s largest shareholders are Vanguard group (6.32M shares, 10.11%), Blackrock (6.15M shares, 9.83%), and Lsv asset management (2.48M shares, 3.97%). Together, they hold 23.90% of Jazz Pharmaceuticals’s total shares outstanding.

Does Blackrock own Jazz Pharmaceuticals?

Yes, BlackRock owns 9.83% of Jazz Pharmaceuticals, totaling 6.15M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 655.94M$. In the last quarter, BlackRock decreased its holdings by -924K shares, a -13.07% change.

Who is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Vestal point capital, lp is Jazz Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 11.94% of its assets in 1.5M Jazz Pharmaceuticals shares, valued at 160.1M$.

Who is the top mutual fund holder of Jazz Pharmaceuticals shares?

Pacer US Cash Cows 100 ETF is the top mutual fund holder of Jazz Pharmaceuticals shares, with 3.49% of its total shares outstanding invested in 2.11M Jazz Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools